How many freeze-thaw cycles will dulaglutide at 20 mg/mL tolerate?

Stated plainly: dulaglutide · 20 mg/mL.

This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory.

What I have done so far is read the label documentation where it exists and the two pharmacopoeial monographs that are publicly available, which cover the licensed presentation and say nothing about a research one.

What is the correct sequence, and where is the step that people usually skip?

Nobody has published a cycle count, and at 20 mg/mL the concentration tells you what a wrong guess costs: a 0.1 mL aliquot holds 2 mg and every microlitre is 20 µg. Damage from freezing is not gradual attrition — it is concentrated at the phase transitions, where ice excludes solute and the unfrozen fraction climbs well above 20 mg/mL for as long as the transition lasts. Two slow cycles can therefore do more than four fast ones, which is why a cycle count is the wrong unit in the first place. The way to make the number one is to make it one: split at reconstitution into single-draw aliquots, label each with 20 mg/mL and the date, and never thaw a container you will refreeze.

Start with how many cycles are actually planned, because one or two are immaterial and ten are not.

Thaw slowly at room temperature or in the refrigerator rather than in warm water. Rapid warming creates local thermal and concentration gradients that promote aggregation.

Count cycles rather than worrying about degrees. Minus twenty and minus eighty differ far less than one cycle and five do.

Selective crystallisation of sodium phosphate buffer components producing large pH shifts on freezing is a classical result in the lyophilisation literature.

Count cycles, not degrees. The cycle is the damaging event.

edited 28 Nov 2025 by esben_lykke — updated for the 2026 guidance change

Answering this needs to know whether the material is dry or in solution, since a dry powder is largely indifferent to a temperature cycle.

Never refreeze a thawed aliquot. The whole point of aliquoting is that the aliquot is single-use, and refreezing it discards the benefit.

Stated carefully, a dry lyophilised powder is much less affected by a temperature cycle because there is no liquid phase for anything to concentrate into. Condensation on a cold vial opened warm is the real risk there.

Thaw slowly and never refreeze an aliquot.

In practice, buffer components crystallise at different rates during freezing, which shifts pH locally by a surprising amount.

Buffer salts crystallise at different points during freezing. Sodium phosphate is the classic example: the dibasic form crystallises first and the pH of the residual liquid falls by several units. That pH excursion is the real damage in many cases.

The mitigation is aliquoting. Divide the reconstituted solution into single-use volumes before the first freeze, and each aliquot then experiences exactly one cycle.

The number of tolerable cycles is sequence- and formulation-dependent and no general number is honest.

Dry powder tolerates cycles far better than solution does.

This is one of the few handling questions with a genuinely quantitative literature behind it.

During freezing, solutes are excluded from the ice lattice and concentrate into the residual liquid. Local concentrations can rise many-fold, which promotes aggregation independently of temperature.

The caveat is that aggregation is invisible in a clear solution below the threshold where it becomes visible.

Aliquot before the first freeze. That is the whole answer.

The short version: aliquot before freezing, thaw slowly, never refreeze a thawed aliquot, and count your cycles.

Let a frozen vial reach room temperature before opening it. Opening a cold vial in humid air condenses water into the cake, which raises residual moisture and undoes what lyophilisation achieved.

Let a frozen vial reach room temperature before opening, or you condense water into it.